drugset
drugset / Trial / NCT00233636

Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck

NCT00233636 ↗

Phase 2 Withdrawn 28 enrolled AstraZeneca
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The aim of the study is to determine if Iressa added to radiotherapy is effective and safe in shrinking tumour dimensions.

Timeline

Start
2003-07
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Gefitinib Small molecule — —

Indications

head and neck cancer squamous cell carcinoma